ConvaTec Group stock

CTEC · LSE · GBp

Compare ConvaTec Group
265.80 GBpChange from previous close: −0.89%Absolute change: −2.40 GBp

Close · November 20, 2026

Price history

+13.30% over the period

1 year: from 234.60 GBp (November 20, 2025) to 265.80 GBp (November 20, 2026), +13.30%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026265.80 GBp
October 30, 2026244.40 GBp
September 30, 2026217.00 GBp
August 28, 2026227.60 GBp
July 31, 2026224.00 GBp
June 30, 2026215.00 GBp
May 29, 2026202.20 GBp
April 30, 2026210.80 GBp
March 31, 2026215.40 GBp
February 27, 2026256.40 GBp
January 30, 2026230.00 GBp
December 31, 2025243.20 GBp
November 28, 2025235.60 GBp
November 20, 2025234.60 GBp

At a glance

  • The company

    Develops, manufactures and sells medical products and technologies for wound care, ostomy care, continence care and infusion care

  • Latest results

    Quarter to June 30, 2026 · EPS $0.09 (estimate $0.09)

TickerLandia's take on ConvaTec Group

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low193.00 GBp
52-wk high272.60 GBp

−2.49% from the 52-week high

Analysts · 19 analysts

Average target312.17 GBp+17.45% vs. price

Buy 18 · Hold 1 · Sell 0 · Strong buy

TickerLandia Fingerprint: ConvaTec Group

Compared with similar companies: very strong momentum.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

ConvaTec Group is pricier than similar companies

ConvaTec Group's P/E (trailing 12 months): 53.2, +55% against the median of a group of 10 similar companies (34.2).

Compared with 10 similar companies

ConvaTec Group's metrics compared with similar companies
MetricConvaTec GroupPosition in the groupBand
P/E (trailing 12 months)53.2High
Forward P/E15.5Low
Operating margin16.3%Middle
ROE7.7%Low
Debt/equity1.22High

Grey band: the middle half of the group; tick: the median; dot: ConvaTec Group. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$1.23B

Latest quarter · Q2 2026

Net income

$54M

Latest quarter · Q2 2026

Quarterly net margin

4.4%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
£5.07B
P/E
53.2
EPS
5.00 GBp
Volume
6.52M
Daily trading
€25.89M
Dividend yield
2.10%
Last ex-dividend on August 20, 2026

How ConvaTec Group is changing

All results
  • Revenue grew 5.2% a year on average over the last 5 years

  • Operating margin rose from 11.8% to 16.8%

  • Profits turn into cash: free cash flow equal to 177% of net income

Returns

ConvaTec Group returns with dividends

£1,000 invested in ConvaTec Group 5 years ago, on November 22, 2021, would be worth £1,382 today with dividends reinvested: +38.15% in total, +6.69% per year. On price alone it would be £1,243 (+24.26%).

PeriodConvaTec GroupFTSE 100£1,000 becomes
1 month+12.91%−3.60%£1,129
6 months+24.09%−0.82%£1,241
Year to date+9.29%+4.18%£1,093
1 year+16.02%+8.59%£1,160
3 years+26.76%+38.02%£1,268
5 years+38.15%+42.60%£1,382
10 years+38.93%+52.65%£1,389

Over the last 6 months it has done better than 57% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. FTSE 100: price only. Calculate your investment

The chart in detail

ConvaTec Group: technical analysis

ConvaTec Group is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 22.7% below its all-time closing high (344.00 GBp, June 5, 2017).

Trend
Upward
RSI (14 sessions)
66
Between 30 and 70
vs 200-session average
+18.33%

Support and resistance

Price areas where ConvaTec Group has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price265.80 GBp
  3. Support245.37 GBp−7.69%3 touches, last on October 26, 2026
  4. Support236.92 GBp−10.87%5 touches, last on November 4, 2026
  5. Support227.70 GBp−14.33%2 touches, last on March 27, 2026

Volatility and risk

Over the last year it has moved roughly in line with the FTSE 100.

Beta (1 year) vs FTSE 100
0.84
Volatility (60 sessions, annualised)
29.7%
Largest fall in the last year
−24.34%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

ConvaTec Group: seasonality

Average monthly price change over 10 years

+0.8%Jan+0.1%Feb+3.7%Mar+2.3%Apr+1.7%May−0.1%Jun−0.2%Jul+0.3%Aug−3.0%Sep−3.4%Oct+1.2%Nov+0.2%Dec

Over the last 10 years, the strongest month for ConvaTec Group has been March: +3.74% on average, positive in 6 years out of 10. The weakest has been October: −3.42% on average, positive in 5 years out of 10. November, the current month, has been positive in 4 years out of 10 (+1.24% on average).

Show chart data
MonthAverageMedianPositive years
January+0.81%+0.59%6 of 10
February+0.08%+0.34%5 of 10
March+3.74%+2.98%6 of 10
April+2.28%−0.33%5 of 10
May+1.70%+1.30%6 of 10
June−0.10%+0.47%5 of 10
July−0.18%+1.68%6 of 10
August+0.26%−0.62%5 of 10
September−2.96%−4.59%2 of 10
October−3.42%+0.02%5 of 10
November+1.24%−1.93%4 of 10
December+0.25%+0.56%6 of 10

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

ConvaTec Group and its competitors

With 10,000 employees, ConvaTec Group Plc develops, manufactures and sells medical products and technologies for managing chronic conditions, mainly in Europe, North America and other international markets. Its wound care range covers chronic wounds linked to diabetes as well as acute wounds from trauma and burns, while its ostomy solutions serve people with a stoma after colorectal or bladder cancer, inflammatory bowel disease or injury.

Headquarters
London, United Kingdom
Employees
10,000
Founded
1978
Chief executive
Jonathan Mason
ConvaTec Group and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
ConvaTec GroupCTEC$6.66B16.3%53.2+24.09%
Ypsomed HoldingYPSN$6.9B31.0%34.9+30.53%
Fielmann GroupFIE$3.93B13.7%16.4−3.95%
SCHOTT Pharma1SXP$3.74B16.4%25.1+34.04%
Tecan GroupTECN$3.58B4.9%—+64.44%
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%

Same industry or related industries, similar size. Compare ConvaTec Group with its competitors · Full profile